BRY 812
Alternative Names: BRY-812Latest Information Update: 18 Sep 2023
At a glance
- Originator BioRay Pharmaceutical
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Immunotoxins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours